Autonomous Reporting & Triage for Chest X-ray
Oxipit offers two complementary CE-marked solutions for chest radiography:
ChestLink – the first autonomous AI that issues a final “normal” report for up to 40% of outpatient chest X-rays, releasing radiologist time for complex cases.
ChestEye – real-time triage that flags pneumothorax, nodules, pleural effusion and 30+ other findings, pushing critical studies to the top of the worklist.
Both tools integrate seamlessly into existing PACS/RIS and have been validated in multi-centre studies across Europe.
Key benefits
- 99% NPV for “normal” reports (Vilnius & Ghent clinical trials, 2022–23)
- Cuts radiologist workload by 15–40% in high-volume CXR services
- Critical-case alert in < 30 s, reducing time-to-diagnosis in the ED
- CE-MDR Class IIb certified; ISO 13485 quality system
Details
- Regulatory: CE-MDR Class IIb | FDA 510(k) submission in progress
- Applications: Pulmonology, Emergency, Screening, Occupational Health
- Modality: Chest X-ray
- Body part: Lungs / Thorax
Clinical evidence
- Vilnius University Hospital Prospective Study (2022): 99.8% NPV across 10,157 outpatient CXRs; 36% autonomously reported as normal.
- Ghent University Hospital Deployment (2023): 28% workload reduction and 21% faster turnaround for flagged critical cases.
For the latest clinical evidence and updates, visit the company’s official website: https://www.oxipit.ai/
Ask K2AI how Oxipit can automate normal chest-X-ray reporting and fast-track critical findings in your radiology workflow.
בניית אתרים JUNAMI